Ocuphire Is In For Phase 2 Trial Investigating Nyxol For Presbyopia
Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine
Results from Lumevoq Phase 1/2a Clinical Trial
GenSight Biologics, a biopharma company focused on developing and
Ducressa® – A New Post-Cataract Surgery Antibiotic/Steroid
Santen Pharmaceutical is one of the world’s leading specialist
